Tuesday | 7 October, 2008
Phosphagenics appoints pharma veteran
Michael Ashton joins Phosphagenics’ board
Additional Resources
Newsletter Subscription
Phosphagenics [ASX: POH] has appointed Michael Ashton to its board as a non-executive director.
Ashton will also act as a consultant on the Melbourne's company's commercialisation strategies.
Ashton has worked for over three decades in the international pharmaceutical industry, including having held senior management positions at Merck, Pfizer and Faulding.
Ashton also served as CEO for SkyePharma PLC.
Australian Life Scientist Member Login
Multimedia Technology signs exclusive National distribution agreement with Freecom 2008-10-07 14:30:00+10
WD Unveils Affordable, High-Capacity Network Storage For Small Offices And Homes 2008-10-07 11:40:00+10
Multimedia Technology & EVERKI sign exclusive distribution agreement. 2008-10-06 14:34:00+10
ONCE A YEAR OPPORTUNITY TO SPEAK TO THE VENDORS! 2008-10-06 13:48:00+10
Virgin Mobile Australia music strategy appointment 2008-10-01 16:48:00+10
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector. ALS is available free of charge to qualified persons working in the life sciences - register now for your free subscription.
